Israel’s largest healthcare provider on Sunday reported a 94% drop in symptomatic COVID-19 infections among 600,000 people who received two doses of the Pfizer’s vaccine in the country’s biggest study to date.
- Advertisement -
Israeli Study Finds 94 Percent Drop in Symptomatic COVID-19 Cases with Pfizer Vaccine
